Total planned funding: $1,862,720,366
Allocations
Countries/Regions
South Africa | $302,677,323 |
Kenya | $283,170,892 |
Nigeria | $267,743,387 |
Tanzania | $167,571,933 |
Ethiopia | $161,681,088 |
Uganda | $147,099,862 |
Zambia | $142,223,541 |
Mozambique | $86,869,076 |
Rwanda | $65,805,974 |
Côte d'Ivoire | $53,365,445 |
Haiti | $52,504,651 |
Namibia | $38,013,161 |
Botswana | $32,454,286 |
Vietnam | $22,153,144 |
Guyana | $11,593,518 |
Zimbabwe | $8,834,334 |
Eswatini | $5,453,000 |
Malawi | $3,569,387 |
Cambodia | $2,953,546 |
India | $2,290,681 |
Ghana | $1,000,000 |
Russia | $885,000 |
China | $793,621 |
Lesotho | $785,000 |
Democratic Republic of the Congo | $772,963 |
Thailand | $305,553 |
Indonesia | $150,000 |
Organizational Types
Unknown | $761,745,670 |
NGO | $340,250,830 |
Private Contractor | $277,379,674 |
University | $235,756,373 |
FBO | $112,360,111 |
Host Country Government Agency | $55,972,375 |
Implementing Agency | $37,479,392 |
Other USG Agency | $23,840,458 |
Own Agency | $11,770,019 |
Parastatal | $3,125,914 |
Multi-lateral Agency | $3,039,550 |
Program Areas
Treatment | $1,862,720,366 |
Budget Codes
HTXS: Treatment: Adult Treatment | $1,075,499,901 |
HTXD: Treatment: ARV Drugs | $682,745,399 |
PDTX: Treatment: Pediatric Treatment | $104,475,066 |